medigraphic.com
Órgano Oficial del Hospital Angeles Health System

2017, Number 2

Next >>

Acta Med 2017; 15 (2)

Is it possible to prevent serious mental illness?

Vázquez EF

Language: Spanish
References: 17
Page: 89-91
PDF size: 93.36 Kb.


Text Extraction

No abstract.


REFERENCES

  1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental disorders. Fifth edition. Washington DC; 2013.

  2. Medina MM, Borges G, Lara C, Benjet C. Prevalencia de trastornos mentales y uso de servicios: resultados de la Encuesta Nacional de Epidemiología Psiquiátrica en México. Salud Ment. 2003; 26: 1-16.

  3. Madrigal EA. Fortalecimiento de la Salud Mental en México: recomendaciones para una psiquiatría comunitaria. Salud Mental. 2016; 39: 235-237.

  4. Gonzalez S, Gupta J, Villa E, Mallawaarachchi I, Rodriguez M, Ramirez M et al. Replication of genome-wide association study (GWAS) susceptibility loci in a Latino bipolar disorder cohort. Bipolar Disord. 2016; 18: 520-527.

  5. Manjarrez G, Vazquez F, Delgado M, Herrera R, Hernandez J. A functional disturbance in the auditory cortex related to a low serotonergic neurotransmission in women with type 2 diabetes. Neuroendocrinology. 2007; 86: 289-294.

  6. Manjarrez G, Cisneros I, Herrera R, Vazquez F, Robles A, Hernandez J. Prenatal impairment of brain serotonergic transmission in infants. J Pediatr. 2005; 147: 592-596.

  7. Nicodemus KK, Marenco S, Batten AJ, Vakkalanka R, Egan MF, Straub RE et al. Serious obstetric complications interact with hypoxiaregulated/ vascular-expression genes to influence schizophrenia risk. Mol Psychiatry. 2008; 13: 873-877.

  8. McGrath JJ, McLaughlin KA, Saha S, Aguilar-Gaxiola S, Al-Hamzawi A, Alonso J et al. The association between childhood adversities and subsequent first onset of psychotic experiences: a cross-national analysis of 23 998 respondents from 17 countries. Psychol Med. 2017; 9: 1-16.

  9. Araujo-Solís MA, Vázquez-Estupiñán MF. Nutrigenética y nutrigenómica. En: Madrazo JA ed. Nutrición y Gastroenterología Pediátrica. Segunda edición. McGraw Hill; 2016.

  10. Niculescu AB, Levey DF, Phalen PL, Le-Niculescu H, Dainton HD, Jain N et al. Understanding and predicting suicidality using a combined genomic and clinical risk assessment approach. Mol Psychiatry. 2015; 20: 1266-1285.

  11. Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003; 301 (5631): 386-389.

  12. Organización Mundial de la Salud. Prevención del suicidio, un imperativo global. Ginebra; 2014.

  13. Nolin M, Malla A, Tibbo P, Norman R, Abdel-Baki A. Early intervention for psychosis in Canada: what is the state of affairs? Can J Psychiatry. 2016; 61: 186-194.

  14. Lieberman JA, Stroup TS, McEvoy JP, Swartz MS, Rosenheck RA, Perkins DO et al. Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) Investigators. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med. 2005; 353: 1209-1223.

  15. The Welcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature. 2007; 447: 661-678.

  16. Harrison PJ, Weinberger DR. Schizophrenia genes, gene expression, and neuropathology: on the matter of their convergence. Mol Psychiatry. 2005; 10: 40-68.

  17. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160 (4): 636-645.




2020     |     www.medigraphic.com